RadNet, Inc. (RDNT) Institutional Ownership & Insider Trading

328 institutions reported holding RadNet, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 15 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RDNTRadNet, Inc.Follow RDNT — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 5.5B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

328 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	328	82	+3.7%	115	28	105	42
Mar 26	338	78	+2.1%	115	36	97	42
Dec 25	338	77	+2.7%	109	32	102	20
Sep 25	319	74	+5.0%	124	31	88	33
Jun 25	324	71	+2.9%	132	40	83	21
Mar 25	302	68	+8.6%	117	35	94	57
Dec 24	322	64	+0.3%	100	39	104	18
Sep 24	296	63	+2.0%	92	40	90	23

RadNet, Inc. — questions

Who owns RadNet, Inc. stock?: 328 institutions reported RadNet, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (13.9%), RTW INVESTMENTS, LP (6.2%), PRICE T ROWE ASSOCIATES INC /MD/ (5.7%).
Are RadNet, Inc. insiders buying or selling?: 15 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from RadNet, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.